Oxybutynin for Post-surgical Bladder Pain and Urgency
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · May 13, 2019
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of a medication called oxybutynin to help relieve bladder pain and urgency that can occur after bladder surgery. The researchers want to find out if using a skin patch (transdermal) to deliver the medication is more effective than taking it by mouth (oral). The goal is to help children aged 4 to 8 who will have bladder surgery and need a catheter afterward, making them eligible for the study.
If your child is selected to participate, they will receive either the skin patch or the oral medication for a set period. It's important to note that children with previous bladder surgeries, certain neurological conditions, or those taking specific medications will not be eligible for the trial. The study is currently recruiting participants, and it aims to provide better treatment options for managing bladder pain and urgency after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who will undergo bladder surgery that requires an indwelling bladder catheter after surgery.
- • Age Range: Four to 8 years of age are eligible for the study.
- Exclusion Criteria:
- • Patients who have had prior bladder surgery.
- • Patients who have neurologic disease that could impair bladder sensation.
- • Patients who are already taking antimuscarinic or antispasmodic medications.
- • Patients with glaucoma, any neurologic disease, dementia, impaired mentation or disorder of the central nervous system.
- • Patients taking any medication that affects the central nervous system such as antidepressant, anxiolytic or antipsychotic medications.
- • Less than four years of age cannot have the transdermal patch due to fixed dose. Over 8 years of age: less than 5% of our patients, who undergo this surgery, are over 8 years of age and is usually a rare adolescent. Data in an older cohort may confuse the results since they respond differently to bladder surgery due to larger incision and longer hospital stay with a catheter.
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Patients applied
Trial Officials
Eric A Kurzrock, MD
Principal Investigator
UC Davis Health Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials